DUBLIN, March 1, 2024 /PRNewswire/ — The “Peripheral Arterial Disease (PAD) Therapeutics: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Peripheral Arterial Disease (PAD) Therapeutics Market to Reach $7 Billion by 2030
The global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$4 Billion in the year 2022, is projected to reach a revised size of US$7 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2022-2030.
Peripheral Stents, one of the segments analyzed in the report, is projected to record a 6.9% CAGR and reach US$1.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Peripheral Angioplasty Balloons segment is readjusted to a revised 6.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 6.7% CAGR
The Peripheral Arterial Disease (PAD) Therapeutics market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 6.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 5.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- PAD – A Prelude
- Recent Market Activity
- PAD Statistics
- Critical Limb Ischemia – An Insight
- High Costs – A Cause of Concern
- Peripheral Arterial Disease (PAD) Therapeutics – Global Key Competitors Percentage Market Share in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
MARKET TRENDS & DRIVERS
- Aging – A Key Driver
- High Diabetes Incidence Worldwide: Key Market Opportunity for PAD Therapeutics
FOCUS ON SELECT PLAYERS (Total 32 Featured)
- AstraZeneca Plc. (UK)
- Bayer HealthCare Pharmaceuticals (Germany)
- Bristol-Myers Squibb Company (US)
- Merck & Co., Inc. (US)
- Proteon Therapeutics, Inc. (US)
- Sanofi S.A. (France)
- Symic Bio, Inc. (US)
- TheraVasc Inc. (US)
For more information about this report visit https://www.researchandmarkets.com/r/gs303a
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:SOURCE Research and Markets
Featured image: Megapixl © Rmarmion
